Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-19-030024

Chief Executive Officer sold 7,800 shares at an average $24.61 ($191,973)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Ciechanover Isaac E. Chief Executive Officer 2019-05-13 Sale −3,500 $24.23 $84,805 300,837 I: show line 1 in the form
Ciechanover Isaac E. Chief Executive Officer 2019-05-13 Sale −400 $24.95 $9,980 300,437 I: show line 2 in the form
Ciechanover Isaac E. Chief Executive Officer 2019-05-14 Sale −3,900 $24.92 $97,188 296,537 I: show line 3 in the form
Open-market sales · 7,800 sh · avg $24.61 · $191,973
Loading xslF345X03/doc4.xml…